WillItSurvive

French digital health insurer combining licensed coverage with an app for care and prevention.

Hard to displace
Assessed 23 July 2026 · Evidence as of 23 July 2026
Strong structural protection; the business model survives ai pressure.
On the recordSince 23 July 2026 · Checkable from 2027 (profitability), late 2026 (Series G close) · Every call on the record Checkpoint: Group-level profitability milestone and Series G regulatory closing
The call

Alan sits on a license few can get and a growing member base, with the real test being whether group profits arrive by 2027 before a big insurer ships a real competing product.

Alan is a health insurance company that started fresh in France in 2016 and Canada more recently, rather than being bought or inherited from an older company. It sells insurance to individuals and groups, and uses software to handle claims and customer service faster than older insurers do. The hard part for competitors is that governments do not easily hand out new insurance licenses, so Alan had a rare opening that older insurers like AXA and Allianz cannot simply recreate by themselves, though those large companies could theoretically launch their own new brand if they chose to. Alan is already profitable in France and has over one million customers, which means it is a real operating business, not just an idea. The one thing that could change everything is whether Alan can turn its whole company profitable by 2027, not just individual countries, and whether the big established insurers actually launch a serious rival product that takes away customers.

Why
01
AI pressure: None apparent. AI can audit claims and answer support tickets but cannot hold insurance risk or a carrier license, so it feeds Alan's tools rather than replacing the policy. Could AI do the core job? Unlikely.
02
Bigger players: AXA, Allianz, Generali. These insurers are slow to digitize and none has shipped a rival product that is actually pulling enterprise clients away from Alan yet. Could a giant copy it? No, they are blocked.
03
What protects it. A rare license: first new independent health insurer in France since 1986 and first new Canadian carrier in about 70 years.
What would change this call
Alan reports group-level profitability progress toward its 2027 breakeven target. Shows whether Alan's growth-at-scale story is on track or slipping.
AXA, Allianz, or Generali launch a digital-native insurance product competing directly with Alan. Would show incumbents are shipping a real rival, not just talking about digital transformation.
French financial regulators approve or delay Alan's €480M Series G closing. Confirms whether Alan's latest funding and valuation actually finalize as announced.
Key numbers
  • €785M ARR, up 53% year over year (2025-12-31)
  • 1.1M+ members across 37,000+ businesses (2026-06-24)
  • €480M Series G at €5.5bn valuation (2026-06-25)
Named risks
  • Group-level profitability still unproven, targeted for 2027 while France alone is profitable. Severity: high
  • Series G closing subject to French financial regulatory approval as of June 25, 2026. Severity: medium
  • Headcount figures across Alan's own disclosures and third-party data are unreconciled, clouding scale claims. Severity: low
  • Reputational spillover risk from CEO's ties to Mistral AI amid Mistral's competitive pressure from DeepSeek and pricing wars in 2026. Severity: low
  • Sector-wide French/EU reimbursement reform could compress insurer margins broadly. Severity: medium
Rivals, as read in July 2026
RivalDirectionEvidence
AXA, Allianz, Generaligaining onAlan grew ARR 53% YoY to €785M by end-2025 while incumbents have not shipped a competing digital-native product
Wakamgaining onWakam needed €85M recapitalization in 2025 plus €34M in early 2026 with SCR below ACPR requirements, while Alan raised €480M in June 2026
Wefox, QovercontestingCited as embedded insurance/platform competitors in SME and broker channels, per vendor-style competitive analysis, March 2026
Sanitas (Bupa/Blua)contestingDescribed as a strong digital-first rival in Spain, one of Alan's expansion markets, per March 2026 secondary source
Questions people ask
Is Alan profitable in 2026?
Alan says it is operationally profitable in France, its largest market, as of March 2026, while group-level break-even is targeted for 2027. Net loss was $56M in 2024, down from $61M in 2023, per company-reported figures cited March 11, 2026.
How much funding has Alan raised?
Alan has raised roughly $1.3B across nine rounds as of June 2026, including a €480M Series G led by Prosus announced June 25, 2026, valuing the French health insurer at about €5.5bn ($6.3bn).
Could AI replace Alan's insurance business?
No. Alan holds an ACPR-regulated French insurance license, the first new one since 1986, and an OSFI federal license in Canada, the first new carrier there in about 70 years. Regulated risk-bearing and capital requirements block pure AI or software entrants from replicating this.
Who is Alan's biggest competitor?
Alan names no shipped rival taking share; large incumbents AXA, Allianz and Generali are cited as slow-moving adjacent competitors (vendor-claimed, March 2026), while peer insurtech Wakam has instead shown financial distress with recapitalizations in 2025 and 2026.
Who owns Alan?
Alan is privately held; founders and employees hold roughly 40% of capital and majority voting rights as of late 2025. Investors include Prosus, Index Ventures, Belfius, and Ontario Teachers', following a €480M Series G announced June 25, 2026.
What is Alan's revenue in 2026?
Alan reported (company-stated) €785M ARR for full-year 2025, up 53% year over year, with Q1 2026 ARR exceeding €800M at the same growth rate, and a target of about €1B ARR ($1.16B) by end of 2026.
Timeline
  • 2026-06-25Alan announces €480M Series G led by Prosus, valuing it at €5.5bn, pending French regulatory approval
  • 2026-06-24Alan reports 1.1M+ members across 37,000+ businesses
  • 2026-03-20Alan reported reaching a $5.83bn valuation per Beinsure
  • 2026-03-12Alan targets €1B ARR by end of 2026
  • 2026-03-11Alan raises €100M ($116M) led by Index Ventures at €5bn valuation, cites France profitability
  • 2026-01Alan launches French-first Quebec employer offering in Canada
  • 2025-12-31Alan headcount reaches ~1,196 employees globally per Revelio Labs, +11% YoY
  • 2024-12-31Alan closes €140M Series F at €4bn valuation, led by Belfius; net loss $56M for the year
  • 2024-12-31Alan receives OSFI federal license, becoming first new Canadian health carrier in ~70 years
Revision history
23 July 2026
First assessed. Hard to displace. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources